WS #14405
There are ongoing developments in the financial sector, including analyst upgrades and earnings forecasts, which may influence market sentiment in the coming days. Keybanc initiates coverage on Westlake with an Overweight rating and a price target of $92. Analysts are revising forecasts for Kestra Medical Technologies ahead of its earnings call. These developments may provide some positive momentum in the financial sector despite the ongoing geopolitical uncertainties.
Financial Sector Developments
There are ongoing developments in the financial sector, including analyst upgrades and earnings forecasts, which may influence market sentiment in the coming days. Keybanc initiates coverage on Westlake with an Overweight rating and a price target of $92. Analysts are revising forecasts for Kestra Medical Technologies ahead of its earnings call. These developments may provide some positive momentum in the financial sector despite the ongoing geopolitical uncertainties.